These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
394 related articles for article (PubMed ID: 6202869)
1. Pharmacological differences between the high-affinity muscarinic agonist binding states of the rat heart and cerebral cortex labeled with (+)-[3H]cismethyldioxolane. Vickroy TW; Roeske WR; Yamamura HI J Pharmacol Exp Ther; 1984 Jun; 229(3):747-55. PubMed ID: 6202869 [TBL] [Abstract][Full Text] [Related]
2. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes. Watson M; Yamamura HI; Roeske WR J Pharmacol Exp Ther; 1986 May; 237(2):411-8. PubMed ID: 3754580 [TBL] [Abstract][Full Text] [Related]
3. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes. Watson M; Roeske WR; Yamamura HI J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581 [TBL] [Abstract][Full Text] [Related]
4. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes. Burke RE Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217 [TBL] [Abstract][Full Text] [Related]
5. Potency ratio for the inhibition of 3H-QNB and 3H-cis-methyldioxolane binding predicts agonist or antagonist activity on muscarinic receptors. Moret C; Pastrie I; Briley M Methods Find Exp Clin Pharmacol; 1988 Oct; 10(10):619-21. PubMed ID: 3236936 [TBL] [Abstract][Full Text] [Related]
6. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists. Gillard M; Waelbroeck M; Christophe J Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611 [TBL] [Abstract][Full Text] [Related]
7. Correlation of the anticholinesterase activity of a series of organophosphates with their ability to compete with agonist binding to muscarinic receptors. Ward TR; Ferris DJ; Tilson HA; Mundy WR Toxicol Appl Pharmacol; 1993 Oct; 122(2):300-7. PubMed ID: 8212012 [TBL] [Abstract][Full Text] [Related]
8. Differential ontogeny of putative M1 and M2 muscarinic receptor binding sites in the murine cerebral cortex and heart. Evans RA; Watson M; Yamamura HI; Roeske WR J Pharmacol Exp Ther; 1985 Dec; 235(3):612-8. PubMed ID: 3841156 [TBL] [Abstract][Full Text] [Related]
9. Characterization of high affinity [3H]pirenzepine and (-)-[3H] quinuclidinyl benzilate binding to muscarinic cholinergic receptors in rabbit peripheral lung. Bloom JW; Halonen M; Lawrence LJ; Rould E; Seaver NA; Yamamura HI J Pharmacol Exp Ther; 1987 Jan; 240(1):51-8. PubMed ID: 3806397 [TBL] [Abstract][Full Text] [Related]
10. [3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerization. Luthin GR; Wolfe BB Mol Pharmacol; 1984 Sep; 26(2):164-9. PubMed ID: 6548291 [TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of binding sites on cardiac muscarinic receptors induced by the neuromuscular blocking agents gallamine and pancuronium. Dunlap J; Brown JH Mol Pharmacol; 1983 Jul; 24(1):15-22. PubMed ID: 6135150 [TBL] [Abstract][Full Text] [Related]
12. Rat cardiac muscarinic receptors. I. Effects of guanine nucleotides on high- and low-affinity binding sites. Waelbroeck M; Robberecht P; Chatelain P; Christophe J Mol Pharmacol; 1982 May; 21(3):581-8. PubMed ID: 7110116 [TBL] [Abstract][Full Text] [Related]
13. The binding of a 2-chloroethylamine derivative of oxotremorine (BM 123) to muscarinic receptors in the rat cerebral cortex. Ehlert FJ; Jenden DJ Mol Pharmacol; 1985 Aug; 28(2):107-19. PubMed ID: 3839562 [TBL] [Abstract][Full Text] [Related]
14. Modulation of muscarinic cholinergic receptor affinity for antagonists in rat heart. Martin MW; Smith MM; Harden TK J Pharmacol Exp Ther; 1984 Aug; 230(2):424-30. PubMed ID: 6379149 [TBL] [Abstract][Full Text] [Related]
15. Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain. Norman AB; Creese I Mol Pharmacol; 1986 Aug; 30(2):96-103. PubMed ID: 3755499 [TBL] [Abstract][Full Text] [Related]
17. Influence of ligand choice on the apparent binding profile of gallamine to cardiac muscarinic receptors. Identification of three main types of gallamine-muscarinic receptor interactions. Lee NH; el-Fakahany EE J Pharmacol Exp Ther; 1988 Sep; 246(3):829-38. PubMed ID: 3418516 [TBL] [Abstract][Full Text] [Related]
18. Binding studies with [3H]cis-methyldioxolane in different tissues. Under certain conditions [3H]cis-methyldioxolane labels preferentially but not exclusively agonist high affinity states of muscarinic M2 receptors. Closse A; Bittiger H; Langenegger D; Wanner A Naunyn Schmiedebergs Arch Pharmacol; 1987 Apr; 335(4):372-7. PubMed ID: 3600816 [TBL] [Abstract][Full Text] [Related]
19. Comparison of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain. Luthin GR; Wolfe BB J Pharmacol Exp Ther; 1984 Mar; 228(3):648-55. PubMed ID: 6546770 [TBL] [Abstract][Full Text] [Related]
20. On the muscarinic receptors in the urinary bladder and the putative subclassification of muscarinic receptors. Nilvebrant L Acta Pharmacol Toxicol (Copenh); 1986; 59 Suppl 1():1-45. PubMed ID: 3524114 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]